Global Companion Diagnostic Technologies Market Trends
The target market is expected to increase due in large part to the increasing global prevalence of cancer disorders. The increasing number of cancer cases is driving up demand for effective CDx (Companion Diagnostic) tests since genetic testing provides physicians with precise information on treatment plans and a clear picture of the patient's tumor. Because of this, the market for companion diagnostic technologies is expanding as sales of CDx (Companion Diagnostic) products rise along with the prevalence of cancer.
For example, a study conducted in 2022 and released by the Indian Council of Medical Research predicted that the number of cancer cases in India would increase from 14.6 lakh in 2022 to 15.7 lakh in 2025.